Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELESTIAL: Insulin for Acute Stroke
NCT00124826Phase 2Completed
- Sponsor
- University of Glasgow
- Start
- May 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human insulin in acute stroke (3 arms), sponsored by University of Glasgow. Primary endpoint: Lesion volume expansion at 1 week. Started May 2004; status: completed.
02
Drugs
human insulin
03
Conditions
acute stroke
Beyond the preview
Go deeper on NCT00124826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124826.